Latest News for Neuren Pharma Stock (OTC:NURPF)

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.

News

Intraday Update

Markets

Movers

Trading Ideas

AAON

AAPL

ADBE

ADGS

ADSK

ADYEY

ADYYF

AEBZY

AFBA

AFGC

AGRX

AGYS

AIQUY

AKAM

ALLE

ALMFF

AMAT

ANSS

APMCF

APPF

ASAZY

ATLC

AUBN

AVGO

AZUL

BABYF

BAESF

BF-B

BMDPY

BUROF

BYDIF

CABO

CACI

CDPYF

CELH

CFBK

CFFA

CGEMY

CGEN

CGNX

CHGCY

CLNXF

CMWAY

COHU

COST

CPRT

CPWHF

CSLLY

CSPI

CVCO

CWCO

DASTY

DBOEF

DCMYY

DEAC

DNNGY

DOGEF

Stocks That Hit 52-Week Highs On Friday

ACGLP

AMWD

ANGPY

ANIK

ASML

BBAVY

BESIY

BLDR

BMMCF

CELG

CHCT

CINF

CMPR

CMRE

CNSWF

CORG

COTQF

COUP

COWP

COWPP

CTAS

DBOEY

DOCU

DOVA

DRTGF

DWVYF

EGFEY

EURN

EXLA

FAST

FERGY

FORTY

FRHC

FRTA

GKNGY

GNRC

HMCBF

HPTN

HWDJF

IMPUY

INGIY

INGXF

INSW

INVH

IXOG

JCOM

KKPNY

MDCO

MDIBY

NGUGF

NURPF

NVMI

ORBN

PBHG

POOL

PTNDY

RDCM

REXR

RLBY

ROST

SALT

SBAZ

SCMWY

SEGXF

SFIN

SIETY

SKSBF

SPNS

SPNUF

SSEZY

SSFT

AGPPF

AMKR

ATHJF

BDUUF

BGAOF

BPYPO

BVSN

CCEL

COLD

DEEL

DJCO

DLRTP

DLTR

ECTE

EDPFY

ESOCF

EVLLF

FFDF

GLIBA

GMRE

HMLA

ITMC

JACK

KDDIY

LEN-B

LGDTF

NFSE

NXRT

OCPNY

ORKLY

PDYPY

PESI

RSKIA

SBGL

SKHSY

SMTI

SQNNY

STNG

TGONF

TMHC

TYOYY

WDFC

WODI

ZYXI

DREUF

BKFKF

MRCBF

GKSDF

KMMPF

DRETF

SRRLF

VPAHF

HBPCF

INFU

ARTR

NEUREN PHARMS LTD ORD by Neuren Pharmaceuticals Ltd.

Neuren Pharmaceuticals Ltd

In a report released on December 21, David Stanton from Jefferies maintained a Buy rating on Neuren Pharmaceuticals Limited (NURPF – Research Repor...

Neuren Pharmaceuticals Limited (NURPF) Receives a Buy from Jefferies

Jefferies analyst David Stanton maintained a Buy rating on Neuren Pharmaceuticals Limited (NURPF – Research Report) on January 11 and set a price t...

Jefferies Sticks to Their Buy Rating for Neuren Pharmaceuticals Limited (NURPF)

In a report released yesterday, Melissa Benson from Wilsons maintained a Buy rating on Neuren Pharmaceuticals Limited (NURPF – Research Report), wi...

Wilsons Sticks to Its Buy Rating for Neuren Pharmaceuticals Limited (NURPF)

Canaccord Genuity analyst Elyse Shapiro maintained a Buy rating on Neuren Pharmaceuticals Limited (NURPF – Research Report) today and set a price t...

Canaccord Genuity Sticks to Their Buy Rating for Neuren Pharmaceuticals Limited (NURPF)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Neuren Pharma Stock (OTC:NURPF)

Friday, January 24, 2020

Friday, October 11, 2019

Friday, October 04, 2019